Clinical Trial Update: Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndrome and juvenile myelomonocytic leukemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Myelomonocytic Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Celgene | Conditions: Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Juvenile | Phase 2 | Status: COMPLETED